GlaxoSmithKline to face class action over anti-depressant used on children

“…Mr Nikolic said one person joining the class action had been prescribed Paroxetine as a six-year-old, and soon began having suicidal thoughts….”

Imagine being prescribed Seroxat at 6 years old…

I wonder does Glaxo CEO Andrew Witty ever think about stuff  like that?

GlaxoSmithKline to face class action over anti-depressant used on children

March 11, 2016 – 9:37PM

Bianca Hall
Bianca Hall
Legal Affairs Reporter for The Age


Paroxetine was once the most commonly used anti-depressant in Australia.

A Sydney law firm has launched a class action on behalf of people who as children and adolescents were prescribed the anti-depressant drug Paroxetine.

Drayton Sher Lawyers has called for expressions of interest from people who were prescribed the drug, commonly known as Aropax in Australia, when they were 18 or younger.

Solicitor Tony Nikolic​ said hundreds of people had indicated they would join the class action, which he expects to file in the Federal Court at the end of May.

Paroxetine was a commonly-prescribed anti-depressant more than a decade ago and for a time was the most commonly used anti-depressant in Australia.

In 2001, GlaxoSmithKline (then SmithKline Beecham) funded a randomised trial of the drug that showed Paroxetine was safe for use in adolescents.

But concerns about its use persisted. In 2004 the Therapeutic Goods Administration’s Adverse Drug Reactions Advisory Committee said there was international concern about the risk of increased suicidal ideation and self-harm among children and adolescents using Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants.

“It should be noted that none of the SSRIs is approved for the treatment of MDD [major depressive disorder] in children or adolescents in Australia, but these drugs are being used for this purpose.”

A team led by the University of Adelaide’s Professor Jon Jureidini re-examined the GlaxoSmithKline research last year and found there were “quite striking” rises in the suicidal thoughts experienced by those taking the drug compared with those taking a placebo.

The review team found that 11 people who took the drug in 2001 experienced experienced suicidal thoughts or behaviours, compared with one person who took the placebo.

Mr Nikolic said one person joining the class action had been prescribed Paroxetine as a six-year-old, and soon began having suicidal thoughts.

“Now, if someone is assisted by this, fine. But they know that these things have suicidal thoughts or ideations attached to them.”

Mr Nikolic is calling for anyone who was, as a minor, prescribed Paroxetine – which also traded under a number of generic names including Chemmart Paroxetine, Extine, GenRx Paroxetine, Paroxetine Actavis and Terry White Chemists Paroxetine – to come forward if they experienced side effects.

These side effects could include suicidal feelings, attempted suicide, and causing others an injury.

Fairfax contacted GlaxoSmithKline for comment.

For help or information call Lifeline on 13 11 14.

Read more:
Follow us: @smh on Twitter | sydneymorningherald on Facebook



  1. kiwi

    Lucire is the Australian Healy and published a article in jan 16

    some developed chronic, and some developed delayed post withdrawal akathisia weeks and months after stopping the medicines and withdrawal akathisia which went on for years was the hardest to manage and reverse. Many remained physically disabled and felt weak and remained on disability support. …..Sometimes suicidality developed for the first time when a dose was missed and when the subject tried to stop taking the drugs.
    Why are we not taking this on board and funding more psychology and psychiatric treatments or detoxification clinics?

    A medical board has determined that medications and doses that had caused people to commit suicide and homicides were ‘standard psychiatric treatmen’t even when the consequence had been fatal. Akathisia cases were not investigated or given any credit. Coroners sitting on five cases of antidepressant – akathisia – related suicides brought before them refused to hear this evidence. Yet the harm done is in plain sight.

    Yolander finishes with a great example from the Holocaust.

    Polish resistance fighter Jan Karski who gave eyewitness testimony to the Supreme Court judge Felix Frankfurter in 1942. Supported by the Polish ambassador, he reported the clearing of the Warsaw ghetto and the systematic murder of Polish Jews in the Belzac concentration camp. Listening to him Frankfurter, himself a Jew, and one of the outstanding legal minds of his generation replied, “I must be frank, I am unable to believe him.” He added, “I did not say this young man is lying. I said I am unable to believe him. There is a difference”.

    This raises the issue of our ability to separate what we know from what we believe, to put aside the things that seem too painful or embarrassing to accept. How is it possible when presented with overwhelming evidence, even the evidence of our own eyes, that we can deliberately ignore something – while being entirely aware that this is what we’re doing? The magnitude and enormity of the lethal nature of Pharma driven biological psychiatry is too painful to tolerate but it cannot go on forever.

    Bravo Yolanda Lucire.
    I applaud you.

  2. kiwi

    Fairfax contacted GSK for comment.

    Let me guess….”no comment” was the reply.

    I cannot tell you have much i am looking forward to seeing GSK go to court!
    Its about time.
    I hope the company is hit so hard it is totally liquidated.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s